April 13th 2017EP. 1: Current CVD Prevention and Management Challenges
April 13th 2017EP. 2: Managed Care Decision Making in CVD and Lipid Control
April 13th 2017EP. 3: Early Detection of Risk and Familial Hypercholesterolemia
April 13th 2017EP. 4: Cholesterol Goals in Primary Cardiovascular Disease Prevention
April 13th 2017EP. 5: Coverage of Statins/Nonstatins in Lipid Management
April 13th 2017EP. 6: Lipid Management: Coverage Criteria vs FDA Labeling
April 13th 2017EP. 7: Efficacy and Safety of PCSK9 Inhibitors
April 13th 2017EP. 8: Management of High-Risk Populations With Hyperlipidemia
April 13th 2017EP. 9: Candidacy for Later-Line Cholesterol-Lowering Therapies
April 13th 2017EP. 10: Alternate Mechanisms of Action for Cholesterol Management
April 13th 2017EP. 11: Clinical Experience With PCSK9 Inhibitors
April 13th 2017EP. 12: PCSK9 Inhibitors: Cost Concerns and Access
April 13th 2017EP. 13: Cholesterol Management and Long-Term Cardiovascular Disease Prevention
April 13th 2017EP. 14: The Future of Lipid Management
April 13th 2017EP. 15: Unmet Needs in Cholesterol Management
